Xcovery Holdings is an evidence-based biopharmaceutical company based in North Palm Beach, FL, dedicated to improving the lives of individuals worldwide facing advanced stages of cancer. With a passion for science, Xcovery aims to develop innovative oncology therapies that are not only more effective but also less toxic and more tolerable for patients. Driven by their mission, Xcovery focuses on the development of potentially groundbreaking treatments such as ensartinib, a potent ALK inhibitor with promising clinical antitumor activity, and vorolanib, a next-generation multikinase angiogenesis inhibitor that has shown efficacy against various cancers. Seeking partnerships and investors, Xcovery aims to launch their therapies globally and develop vorolanib as an ideal combination partner for immuno-oncology therapies.Generated from the website

Mark R Stein, MD - Allergy Associates of the Palm Beaches

Alan P Koterba, MD - Allergy Associates of the Palm Beaches

DR Alan Koterba MD

Rockies Camp LLC